JP2016532643A5 - - Google Patents

Download PDF

Info

Publication number
JP2016532643A5
JP2016532643A5 JP2016520591A JP2016520591A JP2016532643A5 JP 2016532643 A5 JP2016532643 A5 JP 2016532643A5 JP 2016520591 A JP2016520591 A JP 2016520591A JP 2016520591 A JP2016520591 A JP 2016520591A JP 2016532643 A5 JP2016532643 A5 JP 2016532643A5
Authority
JP
Japan
Prior art keywords
delivery device
transdermal delivery
acid
dexmedetomidine
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016520591A
Other languages
English (en)
Japanese (ja)
Other versions
JP6231670B2 (ja
JP2016532643A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/059058 external-priority patent/WO2015054063A1/en
Publication of JP2016532643A publication Critical patent/JP2016532643A/ja
Publication of JP2016532643A5 publication Critical patent/JP2016532643A5/ja
Application granted granted Critical
Publication of JP6231670B2 publication Critical patent/JP6231670B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016520591A 2013-10-07 2014-10-03 非鎮静性デクスメデトミジン経皮組成物を用いる、離脱症候群の治療法及び組成物 Active JP6231670B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361887871P 2013-10-07 2013-10-07
US61/887,871 2013-10-07
PCT/US2014/059058 WO2015054063A1 (en) 2013-10-07 2014-10-03 Methods and compositions for treating withdrawal syndromes using non-sedative dexmedetomidine transdermal compositions

Publications (3)

Publication Number Publication Date
JP2016532643A JP2016532643A (ja) 2016-10-20
JP2016532643A5 true JP2016532643A5 (https=) 2017-09-28
JP6231670B2 JP6231670B2 (ja) 2017-11-15

Family

ID=52777130

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016520591A Active JP6231670B2 (ja) 2013-10-07 2014-10-03 非鎮静性デクスメデトミジン経皮組成物を用いる、離脱症候群の治療法及び組成物

Country Status (11)

Country Link
US (1) US20150098983A1 (https=)
EP (1) EP3054934B1 (https=)
JP (1) JP6231670B2 (https=)
KR (2) KR20160055934A (https=)
CN (1) CN105682650B (https=)
CA (1) CA2924190C (https=)
ES (1) ES2983565T3 (https=)
FI (1) FI3054934T3 (https=)
RU (1) RU2648817C2 (https=)
TW (1) TWI624278B (https=)
WO (1) WO2015054063A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2924233C (en) * 2013-10-07 2018-10-23 Teikoku Pharma Usa, Inc. Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions
GB201600918D0 (en) * 2016-01-18 2016-03-02 Buzzz Pharmaceuticals Ltd Transdermal patch
TWI764951B (zh) * 2016-10-31 2022-05-21 美商帝國製藥美國股份有限公司 用於處理疼痛之右美托咪啶經皮遞送裝置
KR102793584B1 (ko) 2016-12-31 2025-04-09 바이오엑셀 테라퓨틱스 인코포레이티드 불안의 치료를 위한 설하 덱스메데토미딘의 용도
CN111447927A (zh) * 2017-12-08 2020-07-24 帝国制药美国公司 纳洛酮经皮给药装置及其使用方法
PL3813802T3 (pl) 2018-06-27 2025-04-22 Bioxcel Therapeutics, Inc. Formulacje błony zawierające deksmedetomidynę i sposoby ich wytwarzania
WO2020006119A1 (en) 2018-06-27 2020-01-02 Bioxcel Therapeutics, Inc. Methods for treating agitation using dexmedetomidine hydrochloride
CA3077561A1 (en) * 2018-10-15 2020-04-15 Amnon VARDI Slow release cannabinoids and products thereof
US20220218689A1 (en) * 2018-10-24 2022-07-14 Saniona A/S Transdermal tropane compositions and methods for using the same
US20220241218A1 (en) * 2019-04-17 2022-08-04 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system
EP3999058A4 (en) * 2019-07-19 2023-05-03 Bioxcel Therapeutics, Inc. NON-SEDATIVE DEXMEDETOMIDINE-BASED TREATMENT REGIMEN
US12364692B2 (en) 2020-02-14 2025-07-22 Teikoku Pharma Usa, Inc. Topical naloxone compositions and methods for using the same
EP4225305A4 (en) * 2020-10-08 2024-10-23 Bioxcel Therapeutics, Inc. TREATMENT OF BIPOLAR DISEASES AND PSYCHOSES WITH DEXMEDETOMIDINE HYDROCHLORIDE
WO2022147537A1 (en) * 2021-01-04 2022-07-07 Bioxcel Therapeutics, Inc. Dexmedetomidine treatment regimens
CN115227638B (zh) * 2022-07-19 2025-03-18 广州新济生物医药研究院有限公司 一种盐酸右美托咪定可溶性微针及其制备方法
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
AU2024253436A1 (en) * 2023-04-04 2025-11-13 Board Of Regents, The University Of Texas System Combinations including methocinnamox

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5217718A (en) * 1989-08-18 1993-06-08 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
GB9111732D0 (en) * 1991-05-31 1991-07-24 Orion Yhtymae Oy The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
CA2222133C (en) * 1995-06-07 2002-12-24 Cygnus, Inc. Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
GB9521680D0 (en) * 1995-10-23 1996-01-03 Orion Yhtymo Oy New use of imidazole derivatives
US5891868A (en) * 1997-11-21 1999-04-06 Kaiser Foundation Health Plan, Inc. Methods for treating postmenopausal women using ultra-low doses of estrogen
NZ510771A (en) * 1998-10-02 2003-08-29 3M Innovative Properties Co Mucosal originated drug delivery systems
US20030170195A1 (en) * 2000-01-10 2003-09-11 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
JP4694967B2 (ja) * 2003-07-31 2011-06-08 久光製薬株式会社 貼付剤
US20090258063A1 (en) * 2006-09-11 2009-10-15 Sekisui Chemical Co., Ltd. Transdermal patch
JP5547065B2 (ja) * 2008-05-15 2014-07-09 久光製薬株式会社 パロノセトロンを含有する経皮吸収製剤
AU2011204315A1 (en) * 2010-01-08 2012-08-02 Recro Pharma, Inc. Topical transdermal dexmedetomidine compositions and methods of use thereof
CN103200944B (zh) * 2010-11-17 2016-05-04 赫克萨尔股份公司 包含丁丙诺啡的经皮治疗系统
WO2013072763A2 (en) * 2011-11-16 2013-05-23 Nometics Inc. Non-sensitizing transdermal clonidine patch
AU2012352528B9 (en) * 2011-12-11 2017-11-02 Baudax Bio, Inc. Intranasal dexmedetomidine compositions and methods of use thereof
US8242158B1 (en) * 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
US20130211351A1 (en) * 2012-01-31 2013-08-15 Gruenenthal Gmbh Pharmaceutical patch for transdermal administration of (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4-b]indol]-4-amine

Similar Documents

Publication Publication Date Title
JP2016532643A5 (https=)
JP2016532641A5 (https=)
JP2016532644A5 (https=)
JP2016532645A5 (https=)
FI3054934T3 (fi) Menetelmät ja koostumukset vieroitusoireyhtymien hoitoon käyttäen ei-sedatiivisia transdermaalisia deksmedetomidiinikoostumuksia
JP6188934B2 (ja) デクスメデトミジン経皮組成物を含む疼痛管理用方法及び組成物
JP6188933B2 (ja) 非鎮静量のデクスメデトミジンの経皮送達用方法及び組成物
FI3360575T3 (fi) Ihon kautta annosteltavat farmaseuttiset koostumukset, jotka käsittävät vaikuttavia aineita
RU2017111271A (ru) Опипрамоловый пластырь
US11197852B2 (en) Continuous delivery of lenalidomide and other immunomodulatory agents
EP3939661B1 (en) Patch
JPWO2019142940A1 (ja) 皮膚貼付用粘着シート
JP2025146913A (ja) ブロナンセリン含有貼付剤、及びその製造方法
JP7045045B2 (ja) 外用剤
EP3207923A1 (en) Adhesive patch
JP2016532642A5 (https=)
CN107484412B (zh) 含有罗匹尼罗的贴剂
JP5642790B2 (ja) 貼付剤及びその粘着力増強方法
JP5623102B2 (ja) セレギリン含有貼付製剤
JP7683987B2 (ja) ブロナンセリン含有貼付剤、及びその製造方法
JP2021506783A (ja) 経皮薬物送達の間にデポを作成するための方法
CN118317769A (zh) 贴剂
WO2023100740A1 (ja) 貼付剤
CN117797130A (zh) S-氯胺酮经皮组合物及其制备方法和应用
WO2021172157A1 (ja) テトラカインを含む外用剤